PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

One in seven bariatric surgery patients turn to new weight loss drugs

More than half who took weight-loss drugs following bariatric surgery did so within four years

2025-08-27
(Press-News.org) Bariatric surgery is usually effective on its own for weight loss, but an increasing proportion of patients who undergo bariatric surgery start taking one of the new glucagon-like 1 peptide receptor agonist (GLP-1) weight-loss drugs in the years after their surgery, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

The researchers analyzed de-identified national electronic health records covering 112,858 individuals who underwent bariatric surgery from January 2015 to May 2023. They found that 14% of those patients used a GLP-1 such as semaglutide (Wegovy) or tirzepatide (Zepbound) during a follow-up period of up to 10 years after surgery. 

Severe obesity or related conditions such as type 2 diabetes pre-surgery was associated with the outcome—as was being female, and undergoing a type of bariatric surgery called sleeve gastrectomy. Individuals with lower post-operative weight loss were more likely to use GLP-1.

GLP-1 drugs were introduced to market in 2005, approved to treat type 2 diabetes, and the first GLP-1 was approved for obesity in 2014. The analysis showed that the rate of post-surgery GLP-1 use increased during the 2015–2025 study window as more powerful GLP-1 drugs such as semaglutide and tirzepatide became available.

The study was published online August 27 in JAMA Surgery.

“These findings make clear that GLP-1 drug therapy after bariatric surgery is increasingly common,” said study senior author Hemalkumar Mehta, PhD, MS, an associate professor in the Bloomberg School’s Department of Epidemiology. “This suggests that we need to learn more about how to optimize this combination of treatments for patients.”

The U.S. adult obesity rate, currently around 40%, has been on the rise for decades. Obesity increases the risks of diabetes, heart attacks, cancer, and other ailments. Bariatric surgery has been considered one of the most effective treatments for obesity, particularly severe obesity. The surgery reduces the stomach’s capacity to digest food, with patients losing one-fourth to one-third of their pre-surgery weight. About 270,000 bariatric surgeries were done in the U.S. in 2023, the most recent year for which data are available.

Despite its overall effectiveness, approximately 20% to 30% of bariatric-surgery patients’ post-surgery weight loss isn’t sufficient or lasting. Several clinical trials and observational studies suggest that GLP-1 drugs are effective in causing weight loss and improved blood sugar control in these cases. But little was known about the rate at which bariatric surgery patients end up using GLP-1s.

In the study, the researchers evaluated a large electronic health records database kept by a health care technology company called TriNetX. Their primary analysis focused on 112,858 American adult patients in the database who underwent one of the two most common types of bariatric surgery—sleeve gastrectomy or Roux-en-Y gastric bypass—during the period from January 2015 through May 2025, did not use GLP-1s for the year before surgery, and met other inclusion criteria.

In follow-up periods that lasted for at least two and up to 10 years, a total of 15,749 patients (14%) began using GLP-1s. About 21% of the latter began using the drugs within two years of surgery, and about 53% within four years.

The study found that, after holding other factors constant, female bariatric-surgery patients were about 61% more likely to use GLP-1 drugs compared to male patients, Black patients 27% more likely than white patients, sleeve gastrectomy patients 42% more likely than Roux-en-Y patients, and type 2 diabetes patients 34% more likely than non-diabetic patients.

The researchers also found that greater pre-operative weight was associated with higher chance of GLP-1 use. Analyzing obesity classification based on body mass index (BMI), the researchers found that compared to overweight patients (BMI between 25 and 29.9), the chances of GLP-1 use were 1.73 times higher among class 1 obesity patients (BMI between 30 and 34.9), 2.19 times higher among class 2 obesity patients (BMI between 35 and 39.9), and 2.69 times higher among patients with class 3 obesity (BMI 40 or higher)—the most severe form.

“These findings raise important questions for future obesity research,” Mehta says. “For example, what is the optimal clinical threshold for prescribing a GLP-1 in terms of timing and the patient’s relative weight after bariatric surgery?”

To Mehta and his colleagues, the substantial frequency of bariatric surgery plus drug therapy suggests this surgery-plus-drug combination has become routine for some patients—and is by now well studied.

“We think in the future, obesity treatment will follow that paradigm for some patients,” he says. “People won’t just use surgery or GLP-1s—they’ll often use both.”

“Use of Glucagon-like Peptide 1 Agonists Among Individuals Undergoing Bariatric Surgery in the U.S.” was co-authored by Minji Kim, Michael Schweitzer, Ji Soo Kim, G. Caleb Alexander, and Hemalkumar Mehta.

The research was supported by the National Institute on Aging (K01 AG070329).

 

END


ELSE PRESS RELEASES FROM THIS DATE:

A nonsurgical path to treating pelvic organ prolapse

2025-08-27
Pelvic organ prolapse (POP) is a disorder that primarily affects older women who have experienced multiple vaginal childbirths.  Repeated vaginal deliveries can cause the muscles and connective tissue that hold the pelvic organs—the vagina, bladder, uterus, urethra, and rectum—to weaken, causing one or more of the organs to drop out of position and bulge or extrude outside the body.  “There’s a breakdown and loss of the elastic matrix which contributes to tissue elasticity, similar to how a rubber band can stretch and recoil,” says Lehigh University ...

Electrons reveal their handedness in attosecond flashes

2025-08-27
We have all been familiar since childhood with the fact that our left and right hands are identical in structure but not in shape. They are mirror images of each other. In everyday life, this means that a left-handed glove does not fit on the right hand. This “handedness” is also a fundamental property of matter: similar to our hands, many molecules exist in two mirror-image versions, which, despite looking confusingly similar, are actually not identical. Chemists call this chirality. The distinction between right- and left-handed chiral molecules ...

Research implicates biomolecular condensates in a type of childhood brain cancer

2025-08-27
(MEMPHIS, Tenn. – August 27, 2025) A study looking at the biophysical properties of an abnormal protein driving cancer cells is giving scientists new therapeutic clues for how to treat ependymoma, the third most common childhood brain tumor. St. Jude Children’s Research Hospital scientists were studying how the fusion protein ZFTA–RELA, implicated in 95% of ependymomas in the brain cortex, drives disease. Results of the study demonstrate that disordered regions of the fusion protein cause the formation of droplets within cells called condensates. The researchers revealed that these “membraneless organelles” are essential for ependymoma ...

AUF1 protein plays anti-aging role by regulating cellular metabolism

2025-08-27
"Thus, our studies revealed regulatory mechanisms of glycolysis-driven cellular senescence by AUF1-mediated decay of PGAM1 and PDP2 mRNAs.” BUFFALO, NY — August 27, 2025 — A new research paper was published in Volume 17, Issue 7 of Aging (Aging-US) on July 24, 2025, titled “RNA-binding protein AUF1 suppresses cellular senescence and glycolysis by targeting PDP2 and PGAM1 mRNAs.” In this study, Hyejin Mun, Chang Hoon Shin, Mercy Kim, Jeong Ho Chang, and Je-Hyun Yoon from the University of Oklahoma and Kyungpook National University investigated how changes in cellular metabolism contribute to aging. ...

How Iceland’s fiery mantle plume scattered ancient volcanoes across the North Atlantic

2025-08-27
What do the rumblings of Iceland’s volcanoes have in common with the now peaceful volcanic islands off Scotland’s western coast and the spectacular basalt columns of the Giant’s Causeway in Northern Ireland? About sixty million years ago, the Icelandic mantle plume—a fountain of hot rock that rises from Earth’s core-mantle boundary—unleashed volcanic activity across a vast area of the North Atlantic, extending from Scotland and Ireland to Greenland. For decades, scientists have puzzled over why this burst of volcanism was so extensive. Now, research led by the University of Cambridge ...

Many patients with advanced cancer feel their treatment is not aligned with their personal care goals

2025-08-27
When faced with advanced cancer, many patients must make deeply personal decisions about their care plan. Some may pursue more aggressive treatment with the primary aim of extending life, while others may wish to prioritize comfort and quality of life.  But according to a new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center and the UCLA Palliative Care Research Center, many people with advanced cancer report that their treatment does not align with their personal care goals. The findings, published in the journal Cancer, reveal that 37% of patients with advanced ...

Older species tend to have large ranges – unless they live on islands

2025-08-27
Every living species on Earth has a unique geographical range, with some being widespread and others being very narrow. Several factors shape a species’ range size – and one of them is the evolutionary age of a species. To investigate how evolutionary age is related to present-day range size, a research team led by scientists from the German Centre for Integrative Biodiversity Research (iDiv), Leipzig University and Naturalis Biodiversity Center compared over 26,000 species of mammals, birds, reptiles, amphibians, reef fishes, and palms. More than 40,000 species are facing extinction worldwide. Species with narrow geographical ranges are ...

Glow-in-the-dark succulents that recharge with sunlight

2025-08-27
From mushrooms that cast a soft green glow to plankton that glimmers sparkling blue, glowing plants are nothing new for nature. Now, scientists are bringing that light to houseplants.  Reporting in the Cell Press journal Matter on August 27, researchers crafted glow-in-the-dark succulents that recharge in sunlight. Injected with light-emitting compounds, the plants can shine in various colors and rival a small night light at their brightest. The simple, low-cost method may help lay the foundation for sustainable, plant-based lighting systems.  “Picture the world of Avatar, where glowing plants light ...

Origin of life breakthrough: Chemists show how RNA might have started to make proteins on early Earth

2025-08-27
Chemists at UCL have shown how two of biology’s most fundamental ingredients, RNA (ribonucleic acid) and amino acids, could have spontaneously joined together at the origin of life four billion years ago. Amino acids are the building blocks of proteins, the “workhorses” of life essential to nearly every living process. But proteins cannot replicate or produce themselves – they require instructions. These instructions are provided by RNA, a close chemical cousin of DNA (deoxyribonucleic acid). In a new study, published in Nature, researchers chemically linked life’s amino acids to RNA in conditions that could ...

Partial heart transplant for congenital heart disease

2025-08-27
About The Study: In this case series, 19 patients underwent partial heart transplant, which appears to be a safe and feasible procedure that enables valve growth, representing a promising solution to overcome the limitations of current nongrowing valve replacement options. Careful follow-up and monitoring are crucial to support the continued expansion of this novel technique. Corresponding Author: To contact the corresponding author, Joseph W. Turek, MD, PhD, MBA, email joseph.turek@duke.edu, To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2025.13580) Editor’s ...

LAST 30 PRESS RELEASES:

Engineers develop solid lubricant to replace toxic materials in farming

Repurposing gemstone polishing waste to create smart cement

Patient-physician messaging by race, ethnicity, insurance type, and preferred language

Unrecognized motor difficulties and developmental coordination disorder in preschool children

Background genetic variants influence clinical features in complex disorders

Smarter battery tech knows whether your EV will make it home

Overactive microRNAs block fat cell development in progeria

Crosswalk confusion: MA drivers flummoxed by pedestrian hybrid beacons, find UMass Amherst researchers

Study shows heart disease mortality disproportionately burdens low-income communities in California

Intracardiac echocardiography recognized as ‘transformative’ imaging modality in new SCAI position statement

Study finds ‘man’s best friend’ slows cellular aging in female veterans

To get representative health data, researchers hand out fitbits

Hiring in high-growth firms: new study explores the timing of organizational changes

Boosting work engagement through a simple smartphone diary

Climate change may create ‘ecological trap’ for species who can’t adapt

Scientists create ChatGPT-like AI model for neuroscience to build one of the most detailed mouse brain maps to date

AI and omics unlock personalized drugs and RNA therapies for heart disease

2023 ocean heatwave ‘unprecedented but not unexpected’

Johns Hopkins researchers develop AI to predict risk of US car crashes

New drug combination offers hope for men with advanced prostate cancer

New discovery finds gene converts insulin-producing cells into blood-sugar boosters

Powerful and precise multi-color lasers now fit on a single chip

Scientists agree chemicals can affect behavior, but industry workers more reluctant about safety testing

DNA nanospring measures cellular motor power

Elsevier Foundation and RIKEN launch “Envisioning Futures” report: paving the way for gender equity and women’s leadership in Japanese research

Researchers discover enlarged areas of the spinal cord in fish, previously found only in four-limbed vertebrates

Bipolar disorder heterogeneity decoded: transforming global psychiatric treatment approaches

Catching Alport syndrome through universal age-3 urine screening

Instructions help you remember something better than emotions or a good night’s sleep

Solar energy is now the world’s cheapest source of power, a Surrey study finds

[Press-News.org] One in seven bariatric surgery patients turn to new weight loss drugs
More than half who took weight-loss drugs following bariatric surgery did so within four years